Chaim Aryeh Schramm

Title: Chaim Aryeh Schramm: Innovator in HIV-1 Research

Introduction

Chaim Aryeh Schramm is a notable inventor based in the Bronx, NY. He has made significant contributions to the field of anti-HIV therapies, particularly through his innovative research on broadly neutralizing monoclonal antibodies.

Latest Patents

Schramm holds a patent for "Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region." This invention relates to anti-HIV therapies and prophylaxis. Specifically, it focuses on broadly neutralizing antibodies against HIV-1, nucleic acids encoding these antibodies, vectors comprising the nucleic acids, and cells and pharmaceutical compositions containing said vectors and/or antibodies. The invention also includes the use of these antibodies and/or vectors for the treatment and/or prevention of HIV-1 infection in a subject. Furthermore, it encompasses a kit containing the antibodies of the invention.

Career Highlights

Throughout his career, Schramm has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Columbia University. His work has been instrumental in advancing the understanding and treatment of HIV.

Collaborations

Some of his notable coworkers include Jason Gorman and John R. Mascola, who have also contributed to the field of HIV research.

Conclusion

Chaim Aryeh Schramm's innovative work in the development of broadly neutralizing antibodies against HIV-1 has the potential to significantly impact the treatment and prevention of HIV infections. His contributions to science and medicine are commendable and highlight the importance of research in combating global health challenges.